Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
xconomy.com » Xconomy Boston - Jul 1, 2008
Roundup, deals, Stocks Rebecca Zacks wrote: Aren’t things supposed to slow down in the summer? There was lots of dealmaking happening in New England last week, across life sciences and high-tech fields …
Also tagged: energy, microsoft, web 2 0, software, web, nanotech, roundup, vc, boston, venture capital, solar, deals, nano, stocks, acquisitions, bezos expeditions, checkpoint systems, life sciences, blogtalkradio, cleantech, cvs caremark, spark capital, industrial defender, gtc biotherapeutics, evergreen solar, healthvault, immunogen, oatsystems, boston blog main, brook venture partners, rockport capital partners, teltone, rxi pharmaceuticals, ziff asset management, security innovation, arcapita ventures, reservoir capital group, lehman brothers venture partners, kraft group, aspen aerogels, biotech pharma
xconomy.com » Xconomy Energy Feed - Jun 30, 2008
Roundup, deals, Stocks Rebecca Zacks wrote: Aren’t things supposed to slow down in the summer? There was lots of dealmaking happening in New England last week, across life sciences and high-tech fields …
Also tagged: energy, microsoft, web 2 0, software, web, nanotech, roundup, vc, boston, venture capital, solar, deals, nano, stocks, acquisitions, bezos expeditions, checkpoint systems, life sciences, blogtalkradio, cleantech, cvs caremark, spark capital, industrial defender, gtc biotherapeutics, evergreen solar, healthvault, immunogen, oatsystems, boston blog main, brook venture partners, rockport capital partners, teltone, rxi pharmaceuticals, ziff asset management, security innovation, arcapita ventures, reservoir capital group, lehman brothers venture partners, kraft group, aspen aerogels, biotech pharma
xconomy.com » Xconomy Boston - Jun 26, 2008
Roundup, Life Sciences, Alliances Rebecca Zacks wrote: New England’s public life sciences firms were feeling particularly newsworthy this last week, it seems. But plenty of private firms are represented in this first …
Also tagged: roundup, biotech, boston, deals, fda, stocks, pharma, carl icahn, alliances, life sciences, genzyme, biogen idec, gtc biotherapeutics, immunogen, isis pharmaceuticals, boston blog main, kyowa hakko kogyo, innovationrx, alnylam pharmaceuticals, rxi pharmaceuticals, ziff asset management
xconomy.com » Xconomy Venture Capital Feed - Jun 25, 2008
Roundup, Life Sciences, Alliances Rebecca Zacks wrote: New England’s public life sciences firms were feeling particularly newsworthy this last week, it seems. But plenty of private firms are represented in this first …
Also tagged: roundup, biotech, boston, deals, fda, stocks, pharma, carl icahn, alliances, life sciences, genzyme, biogen idec, gtc biotherapeutics, immunogen, isis pharmaceuticals, boston blog main, kyowa hakko kogyo, innovationrx, alnylam pharmaceuticals, rxi pharmaceuticals, ziff asset management
xconomy.com » Xconomy - Jun 24, 2008
Biotech, deals, Pharming Luke Timmerman wrote: GTC Biotherapeutics is gearing up to take its first “pharming” product, a drug harvested from genetically modified goats, to the U.S. market. The Framingham, MA-based …
Also tagged: national, biotech, deals, fda, pharming, life sciences, gtc biotherapeutics, atryn, boston blog main, national blog main, leo pharma
fiercebiotech.com » Untitled News Source - Jun 23, 2008
Shares of GTC Therapeutics were shooting up this morning after the company announced it had inked a $257 million licensing deal with Ovation Pharmaceuticals for its blood clotting therapy ATryn. Ovation gets sales and …
Also tagged: transgenics, gtc therapeutics